Carmine Oddis is a Cardiology physician. OpenAlex indexes 52 publications with 4,336 citations (h-index 22).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1062 Forsyth St Ste 1b
Macon, GA 312018638
Telephone
478-741-1208Provider last certified this registry record 19 May 2026.
Industry payments
28 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20257 payments
- Medtronic, Inc.Program year20256 payments
- PFIZER INC.Program year202511 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
61.5%Antiarrhythmic21.1%Flecainide Acetate50%Amiodarone Hcl27%Propafenone Hcl13%Mexiletine Hcl4%Dofetilide3%Propafenone Hcl Er2%Multaq1%Pacerone1%Part D<11 patientsBeta blocker13.1%Metoprolol Succinate38%Carvedilol15%Sotalol14%Metoprolol Tartrate14%Pindolol6%Acebutolol Hcl5%Labetalol Hcl4%Atenolol2%Nebivolol Hcl2%Nadolol1%Propranolol Hcl1%Part D<11 patients+ 20 more classes in this area
Blood & clotting
19.1%Factor Xa inhibitor16.3%Eliquis74%Xarelto26%Part D≥332 patientsP2Y12 inhibitor1.3%Clopidogrel86%Prasugrel Hcl14%Part D<11 patients+ 2 more classes in this area
Nervous system
10.5%Cholinesterase Inhibitor4.6%Pyridostigmine Bromide100%Part D≥195 patientsCentral Nervous System Stimulant3.4%Methylphenidate Hcl94%Dextroamphetamine-Amphetamine6%Part D<11 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- POS1026 CONSENSUS NOMENCLATURE AND ABBREVIATION FOR ANTI-SYNTHETASE SYNDROME: RESULTS FROM AN IMACS PROJECT
Annals of the Rheumatic Diseases
2025 - POS1439 POLOXAMERS 188 & 182 ARE EFFECTIVE IN REPAIRING THE MEMBRANE RESEALING DEFECT IN MYOSITIS
Annals of the Rheumatic Diseases
2025 - POS1064 CORRELATIONS OF CK CHANGES WITH OUTCOME MEASURES IN MYOSITIS: SUBGROUP DIFFERENCES
Annals of the Rheumatic Diseases
2025 - POS0274 PROGNOSTIC SIGNIFICANCE OF 1-YEAR PULMONARY FUNCTION CHANGES IN MYOSITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
Annals of the Rheumatic Diseases
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”